#ThinkSabio US Market Morning Brief
Pre-Market Gainers
$IBO + 154%: Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
$CDTX + 70%: Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
$OP + 48%:
$FBRX + 33%: Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
Pre-Market Decliners:
$CMPS – 36%: Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
$NXTT – 33%
Pre-Market Penny Gainers:
$INDP + 87%: Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants(June 13)
$PTLE + 18%
$LPTX +18: Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives
Headlines
$AMZN AWS confirms cloud partnership with SK Group with 15-year deal
$NVO $HIMS NOVO NORDISK – TERMINATES COLLABORATION WITH HIMS & HERS HEALTH, INC